Seven $1 billion-plus drugs seen reaching market in 2016
Go back to Seven $1 billion-plus drugs seen reaching market in 2016| AbbVie (NYSE: ABBV) | Delayed: 250.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $250.09 | 52 Week High | $68.12 | |||
| Open | $250.09 | 52 Week Low | $50.71 | |||
| Day High | $250.09 | P/E | 54.25 | |||
| Day Low | $250.09 | EPS | $4.61 | |||
| Volume | 3,488 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 135.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.77 | 52 Week High | $108.63 | |||
| Open | $135.77 | 52 Week Low | $71.39 | |||
| Day High | $135.77 | P/E | 75.01 | |||
| Day Low | $135.77 | EPS | $1.81 | |||
| Volume | 1,565 | |||||
| INTERCEPT PHARM (NASDAQ: ICPT) | Delayed: 19.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.00 | 52 Week High | $186.87 | |||
| Open | $213.72 | 52 Week Low | $89.76 | |||
| Day High | $19.00 | P/E | N/A | |||
| Day Low | $19.00 | EPS | $-5.79 | |||
| Volume | 2,412,753 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 130.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.42 | 52 Week High | $65.46 | |||
| Open | $130.42 | 52 Week Low | $47.97 | |||
| Day High | $130.42 | P/E | 88.72 | |||
| Day Low | $130.42 | EPS | $1.47 | |||
| Volume | 923,014 | |||||
| ROGERS CORPORATION (NYSE: ROG) | Delayed: 135.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.06 | 52 Week High | $76.55 | |||
| Open | $135.06 | 52 Week Low | $41.92 | |||
| Day High | $135.06 | P/E | 76.31 | |||
| Day Low | $135.06 | EPS | $1.77 | |||
| Volume | 1,548 | |||||

